Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3306

1.

Small bowel stenosis: a manifestation of chronic graft-versus-host disease in children?

Tordjman M, Ouachee M, Bonnard A, Tilea B, Yakouben K, Viala J, Peuchmaur M, Berrebi D.

Hum Pathol. 2017 Sep 9. pii: S0046-8177(17)30323-4. doi: 10.1016/j.humpath.2017.08.034. [Epub ahead of print]

PMID:
28899741
2.

Recovery of Pulmonary Function after Allogeneic Hematopoietic Cell Transplantation in Children is Associated with Improved Survival.

Srinivasan A, Sunkara A, Mitchell W, Sunthankar S, Kang G, Stokes DC, Srinivasan S.

Biol Blood Marrow Transplant. 2017 Aug 30. pii: S1083-8791(17)30678-X. doi: 10.1016/j.bbmt.2017.08.025. [Epub ahead of print]

PMID:
28865973
3.

Rituximab-based first line treatment for chronic GVHD after allogeneic SCT: results of a phase 2 study.

Malard F, Labopin M, Yakoub-Agha I, Chantepie S, Guillaume T, Blaise D, Tabrizi R, Magro L, Vanhove B, Blancho G, Moreau P, Gaugler B, Chevallier P, Mohty M.

Blood. 2017 Sep 1. pii: blood-2017-05-786137. doi: 10.1182/blood-2017-05-786137. [Epub ahead of print]

PMID:
28864814
4.

Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in Allogeneic Stem Cell Transplantation: Systematic Literature Review and Network Meta-Analysis.

Gagelmann N, Ayuk F, Wolschke C, Kröger N.

Biol Blood Marrow Transplant. 2017 Aug 29. pii: S1083-8791(17)30680-8. doi: 10.1016/j.bbmt.2017.08.027. [Epub ahead of print]

PMID:
28864138
5.

Mesenchymal Stem Cells May Ameliorate Nephrotic Syndrome Post-Allogeneic Hematopoietic Stem Cell Transplantation-Case Report.

Zhang X, Peng Y, Fan Z, Zhao K, Chen X, Lin R, Sun J, Wang G, Xiang A, Liu Q.

Front Immunol. 2017 Aug 14;8:962. doi: 10.3389/fimmu.2017.00962. eCollection 2017.

6.

An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.

Poe JC, Jia W, Su H, Anand S, Rose JJ, Tata PV, Suthers AN, Jones CD, Kuan PF, Vincent BG, Serody JS, Horwitz ME, Ho VT, Pavletic SZ, Hakim FT, Owzar K, Zhang D, Blazar BR, Siebel CW, Chao NJ, Maillard I, Sarantopoulos S.

Blood. 2017 Aug 29. pii: blood-2017-05-782466. doi: 10.1182/blood-2017-05-782466. [Epub ahead of print]

PMID:
28851699
7.

Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.

Caocci G, Orofino MG, Vacca A, Piroddi A, Piras E, Addari MC, Caria R, Pilia MP, Origa R, Moi P, La Nasa G.

Am J Hematol. 2017 Aug 29. doi: 10.1002/ajh.24898. [Epub ahead of print]

PMID:
28850704
8.

Pulmonary Injury and Chronic Graft-versus-Host Disease: Do We Miss the Signs and Symptoms?

Hildebrandt GC.

Biol Blood Marrow Transplant. 2017 Aug 16. pii: S1083-8791(17)30650-X. doi: 10.1016/j.bbmt.2017.08.015. [Epub ahead of print] No abstract available.

PMID:
28822829
9.

Clinical risks and healthcare utilization of haematopoietic cell transplantation for sickle cell disease in the U.S. using merged databases.

Arnold SD, Brazauskas R, He N, Li Y, Aplenc R, Jin Z, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, Majhail NS, Diaz MA, Freytes CO, Wood WA, Savani BM, Kamble RT, Parsons S, Ahmed I, Sullivan K, Beattie S, Dandoy C, Munker R, Marino S, Bitan M, Abdel-Azim H, Aljurf M, Olsson RF, Joshi S, Buchbinder D, Eckrich MJ, Hashmi S, Lazarus H, Marks DI, Steinberg A, Saad A, Gergis U, Krishnamurti L, Abraham A, Rangarajan HG, Walters M, Lipscomb J, Saber W, Satwani P.

Haematologica. 2017 Aug 17. pii: haematol.2017.169581. doi: 10.3324/haematol.2017.169581. [Epub ahead of print]

10.

A cross-sectional study on late taste disorders in survivors of allogeneic hematopoietic cell transplantation.

Sato T, Konuma T, Miwa Y, Sugihara N, Tsuru Y, Narita H, Kiriyama S, Kato S, Oiwa-Monna M, Kobayashi K, Takahashi S, Tojo A.

Ann Hematol. 2017 Aug 16. doi: 10.1007/s00277-017-3087-6. [Epub ahead of print]

PMID:
28815326
11.

Current and emerging treatment options for mantle cell lymphoma.

Fakhri B, Kahl B.

Ther Adv Hematol. 2017 Aug;8(8):223-234. doi: 10.1177/2040620717719616. Epub 2017 Jul 7. Review.

12.

Monitoring of Busulphan Concentrations in Children Undergone Hematopoietic Stem Cell Transplantation: Unicentric Experience over 10 years.

Faraci M, Tinelli C, Lanino E, Giardino S, Leoni M, Ferretti M, Castagnola E, Broglia M, De Silvestri A, Di Martino D, Bartoli A.

Eur J Drug Metab Pharmacokinet. 2017 Aug 11. doi: 10.1007/s13318-017-0431-0. [Epub ahead of print]

PMID:
28801891
13.

Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients.

Curtis LM, Pirsl F, Steinberg SM, Mitchell SA, Baird K, Cowen EW, Mays J, Buxbaum NP, Pichard DC, Im A, Avila D, Taylor T, Fowler DH, Gress RE, Pavletic SZ.

Biol Blood Marrow Transplant. 2017 Aug 7. pii: S1083-8791(17)30627-4. doi: 10.1016/j.bbmt.2017.08.005. [Epub ahead of print]

PMID:
28797782
14.

Vulvovaginal Graft-Versus-Host Disease.

Kornik RI, Rustagi AS.

Obstet Gynecol Clin North Am. 2017 Sep;44(3):475-492. doi: 10.1016/j.ogc.2017.05.007. Review.

PMID:
28778644
15.

A review of late complications of allogeneic hematopoietic stem cell transplantations.

Atilla E, Atilla PA, Toprak SK, Demirer T.

Clin Transplant. 2017 Jul 28. doi: 10.1111/ctr.13062. [Epub ahead of print] Review.

PMID:
28753218
16.

Efficacy and Safety of Topical Corticosteroids for Management of Oral Chronic Graft versus Host Disease.

Elsaadany BA, Ahmed EM, Aghbary SMH.

Int J Dent. 2017;2017:1908768. doi: 10.1155/2017/1908768. Epub 2017 Jul 2. Review.

17.

TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells.

Suthers AN, Sarantopoulos S.

Front Immunol. 2017 Jul 13;8:775. doi: 10.3389/fimmu.2017.00775. eCollection 2017. Review.

18.

Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host Disease.

Balakrishnan A, Gloude N, Sasik R, Ball ED, Morris GP.

Biol Blood Marrow Transplant. 2017 Jul 24. pii: S1083-8791(17)30607-9. doi: 10.1016/j.bbmt.2017.07.016. [Epub ahead of print]

PMID:
28750779
19.

A monoclonal antibody against CD86 and its protection in a murine lupus nephritis model of chronic graft-versus-host disease.

Han L, Shen L, Zhu Y, Qiu Y.

Immunopharmacol Immunotoxicol. 2017 Oct;39(5):285-291. doi: 10.1080/08923973.2017.1354878. Epub 2017 Jul 26.

PMID:
28747139
20.

Outcomes of Hematopoietic Stem Cell Transplantation at a Limited-Resource Center in Mexico Are Comparable to Those in Developed Countries.

Leon Rodriguez E, Rivera Franco MM.

Biol Blood Marrow Transplant. 2017 Jul 18. pii: S1083-8791(17)30580-3. doi: 10.1016/j.bbmt.2017.07.010. [Epub ahead of print]

PMID:
28733265

Supplemental Content

Loading ...
Support Center